Consumer

Daily Consumer: Starbucks (SBUX): China Strategy Reaped by Luckin’s Parasitical Tactic, a Visit and Case Study and more

In this briefing:

  1. Starbucks (SBUX): China Strategy Reaped by Luckin’s Parasitical Tactic, a Visit and Case Study
  2. Goldwin Tops Sports Market Growth Through Store Investment
  3. Hengan Intl. (1044 HK): Our Analysis Suggests that Bonitas’ Allegations Have Some Substance

1. Starbucks (SBUX): China Strategy Reaped by Luckin’s Parasitical Tactic, a Visit and Case Study

Pic%203 4

  • We believe Luckin copies SBUX’s site selection, but chooses low rental places close to Starbucks shops.
  • Starbucks plans to add delivery business to raise margins and comparable store sales, but Luckin has focused on delivery since inception.
  • Starbucks needs the China market as its growth momentum, but we believe Luckin’s parasitical tactic will be a major resistance.

2. Goldwin Tops Sports Market Growth Through Store Investment

Mizuno

Marketing of sports brands has become increasingly retail-led in the last decade and a focus on retailing has enabled Goldwin (8111 JP) to make serious gains while the two biggest domestic brands, Asics Corp (7936 JP) and Mizuno Corp (8022 JP), have been distracted by overseas expansion.

Goldwin took a close look at its beleaguered business 15 years ago and decided retail could be its salvation.

At current rates it will catch up with Mizuno’s domestic sales in a few years.

Overall, we are bullish about Goldwin but also the wider sports category because sports and sports fashion is in many ways one of the few consumer categories to be largely immune to a demographically challenged market like Japan – all age segments are buying into sports apparel, including the over 60s.

3. Hengan Intl. (1044 HK): Our Analysis Suggests that Bonitas’ Allegations Have Some Substance

Balance%20sheet%20profile

Hengan Intl Group (1044 HK), China’s leading sanitary towel and nappy producer, has been targeted by a short seller, Bonitas Research. Hengan has denied Bonitas’ allegations to which Bonitas has responded that Hengan’s response was weak and evasive. The shares have continued to slide suggesting that investors are less than convinced with Hengan’s rebuttal.

The aim of our note is to analyse alternative financial metrics to judge if Bonitas’ allegations are groundless or have some substance. Overall, our analysis suggests that Bonitas’ claims have some substance and investors should not be so quick to dismiss them.